Cargando…
Identification of germline alterations of the mad homology 2 domain of SMAD3 and SMAD4 from the Ontario site of the breast cancer family registry (CFR)
INTRODUCTION: A common feature of neoplastic cells is that mutations in SMADs can contribute to the loss of sensitivity to the anti-tumor effects of transforming growth factor-β (TGF-β). However, germline mutation analysis of SMAD3 and SMAD4, the principle substrates of the TGF-β signaling pathway,...
Autores principales: | Tram, Eric, Ibrahim-zada, Irada, Briollais, Laurent, Knight, Julia A, Andrulis, Irene L, Ozcelik, Hilmi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3236341/ https://www.ncbi.nlm.nih.gov/pubmed/21835029 http://dx.doi.org/10.1186/bcr2926 |
Ejemplares similares
-
Methodological issues in detecting gene-gene interactions in breast cancer susceptibility: a population-based study in Ontario
por: Briollais, Laurent, et al.
Publicado: (2007) -
A Whole-Genome SNP Association Study of NCI60 Cell Line Panel Indicates a Role of Ca(2+) Signaling in Selenium Resistance
por: Savas, Sevtap, et al.
Publicado: (2010) -
MAD‐related Genes on 18q21.1, Smad2 and Smad4, Are Altered Infrequently in Esophageal Squamous Cell Carcinoma
por: Maesawa, Chihaya, et al.
Publicado: (1997) -
Drosophila Smad2 Opposes Mad Signaling during Wing Vein Development
por: Sander, Veronika, et al.
Publicado: (2010) -
Combined effect of CCND1 and COMT polymorphisms and increased breast cancer risk
por: Onay, Ummiye V, et al.
Publicado: (2008)